These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21948905)

  • 21. Treatment of refractory substance-induced psychosis in adolescent males with a genetic predisposition to mental illness.
    Rahmani M; Paul S; Nguyen ML
    Int J Adolesc Med Health; 2014; 26(2):297-301. PubMed ID: 24762642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zotepine in levodopa-induced Psychosis.
    Spieker S; Stetter F; Klockgether T
    Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
    [No Abstract]   [Full Text] [Related]  

  • 23. [Psychosis of supersensitivity or tardive psychosis of neuroleptics. A complication of long-term neuroleptic treatment?].
    Bourgeois M
    Ann Med Psychol (Paris); 1987 Feb; 145(2):161-3. PubMed ID: 2887140
    [No Abstract]   [Full Text] [Related]  

  • 24. Clozapine in drug-induced psychosis in Parkinson's disease. The French Clozapine Parkinson Study Group.
    Lancet; 1999 Jun; 353(9169):2041-2. PubMed ID: 10376627
    [No Abstract]   [Full Text] [Related]  

  • 25. Rhabdomyolysis and antipsychotics.
    Rodríguez Fernández L; Martín Asenjo M; González Fuentes R
    Med Clin (Barc); 2019 Aug; 153(4):179-180. PubMed ID: 30595369
    [No Abstract]   [Full Text] [Related]  

  • 26. The efficacy of ECT in phencyclidine-induced psychosis.
    Rosen AM; Mukherjee S; Shinbach K
    J Clin Psychiatry; 1984 May; 45(5):220-2. PubMed ID: 6144671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organic psychosis induced by ofloxacin and metronidazole.
    Koul S; Bhan-Kotwal S; Jenkins HS; Carmaciu CD
    Br J Hosp Med (Lond); 2009 Apr; 70(4):236-7. PubMed ID: 19357607
    [No Abstract]   [Full Text] [Related]  

  • 28. Reserpine and phencyclidine-associated psychosis: three case reports.
    Berlant JL
    J Clin Psychiatry; 1985 Dec; 46(12):542-4. PubMed ID: 2866179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent psychosis associated with salvia divinorum use.
    Przekop P; Lee T
    Am J Psychiatry; 2009 Jul; 166(7):832. PubMed ID: 19570943
    [No Abstract]   [Full Text] [Related]  

  • 30. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.
    Moncrieff J
    Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication-induced dystonias in nine patients with dementia.
    Magnuson TM; Roccaforte WH; Wengel SP; Burke WJ
    J Neuropsychiatry Clin Neurosci; 2000; 12(2):219-25. PubMed ID: 11001600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
    Ekinci O; Sabuncuoglu O
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):648-9. PubMed ID: 21134409
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis.
    van Nimwegen-Campailla L; van Beveren N; Laan W; van den Brink W; Linszen D; de Haan L
    Pharmacopsychiatry; 2010 Nov; 43(7):281. PubMed ID: 20839158
    [No Abstract]   [Full Text] [Related]  

  • 34. Radioactive iodine-induced psychosis.
    Freeman SA
    Am J Psychiatry; 2009 Sep; 166(9):1067-8. PubMed ID: 19723801
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of the antipsychotic action of certain neuroleptics modeled on LSD psychosis].
    Krendal' FP; Kudrin AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):747-53. PubMed ID: 4146259
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S; Factor SA; Molho ES; Feustel PJ
    Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term study.
    Meco G; Alessandri A; Giustini P; Bonifati V
    Mov Disord; 1997 Jul; 12(4):610-2. PubMed ID: 9251085
    [No Abstract]   [Full Text] [Related]  

  • 38. Developing and testing adaptive treatment strategies using substance-induced psychosis as an example.
    Dawson R; Green AI; Drake RE; McGlashan TH; Schanzer B; Lavori PW
    Psychopharmacol Bull; 2008; 41(3):51-67. PubMed ID: 18779776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of antiparkinsonian drug toxicity by physostigmine: a controlled study.
    el-Yousef MK; Janowsky D; Davis JM; Sekerke HJ
    Am J Psychiatry; 1973 Feb; 130(2):141-5. PubMed ID: 4405503
    [No Abstract]   [Full Text] [Related]  

  • 40. Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open label pilot study.
    Friedman JH; Goldstein S; Jacques C
    Clin Neuropharmacol; 1998; 21(5):285-8. PubMed ID: 9789708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.